Insiders · Profile

Naftzger J. Christopher

General Counsel and CCO at Arbutus Biopharma. Filing since 4 Feb 2025. CIK 0001496194

Company

Date

Role

Action

Amount

Of holding

4 Feb 2025

General Counsel and CCO

Sold on a plan

11,333

$37.21K

11.6%

1 decision on file.